The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A Phase 3, randomized, double-blind, placebo-controlled study of tasquinimod (TASQ) in men with metastatic castration-resistant prostate cancer (mCRPC), secondary endpoints.
 
Cora N. Sternberg
Honoraria - Argos Therapeutics; Astellas Pharma; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Ipsen; Janssen; Lilly/ImClone; Merck; Millennium; Novartis; Oncogenex; Pfizer; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Bayer; Novartis
 
Andrew J. Armstrong
Honoraria - Dendreon; Sanofi
Consulting or Advisory Role - Bayer; Dendreon; Janssen Biotech; Medivation; Novartis; Sanofi
Speakers' Bureau - Dendreon
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); ImClone Systems (Inst); Janssen Oncology (Inst); KangLaiTe (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Dendreon; Janssen Biotech; Medivation
 
Roberto Pili
Research Funding - Active Biotech
 
Tore Nederman
Employment - Active Biotech
 
Michael Anthony Carducci
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Blue Earth Diagnostics; Medivation